ATYR PHARMA, INC. (ATYR) Free cash flow 2016–2025
ATYR PHARMA, INC. (ATYR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$62.1MFY2025 · since FY2016: -$53.5M → -$62.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.1M | +10.3% |
| FY2024 | -$69.2M | -84.8% |
| FY2023 | -$37.4M | +14.0% |
| FY2022 | -$43.5M | -30.8% |
| FY2021 | -$33.3M | -114.6% |
| FY2020 | -$15.5M | +22.8% |
| FY2019 | -$20.1M | +36.5% |
| FY2018 | -$31.7M | +27.5% |
| FY2017 | -$43.7M | +18.3% |
| FY2016 | -$53.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice